drugset / Trial / NCT00262678

Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients.

NCT00262678

Phase 3 Completed Kyowa Kirin, Inc.
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine the effectiveness and safety of sublingual fentanyl tablets in relieving breakthrough pain in cancer patients.

Timeline

Start
2005-12
Primary completion
2008-12
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified Other

Indications